🇺🇸 Renin-angiotensin-aldosterone system inhibitors in United States

Renin-angiotensin-aldosterone system inhibitors (Renin-angiotensin-aldosterone system inhibitors) regulatory status in United States.

Marketing authorisation

FDA

  • Status: approved

Renin-angiotensin-aldosterone system inhibitors in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is Renin-angiotensin-aldosterone system inhibitors approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for Renin-angiotensin-aldosterone system inhibitors in United States?

National Heart Centre Singapore is the originator. The local marketing authorisation holder may differ — check the official source linked above.